Diamyd Medical receives GMP certification and manufacturing authorization for biological investigational medicinal products for human use

Diamyd Medical today announced a significant advancement in the company’s operations related to the manufacturing of biological medicines (biologics). The company has now received GMP (Good Manufacturing Practice) certification as well as manufacturing authorization from the Swedish Medical Products Agency for the production of biological investigational medicinal products for human use. The certification and authorization confirm that Diamyd Medical’s manufacturing facility complies with current regulatory requirements and international quality standards for pharmaceutical production.